share_log

Profound Medical Analyst Ratings

Profound Medical Analyst Ratings

深厚的医学分析师评级
Benzinga ·  2023/11/28 04:21
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/28/2023 32.53% Stifel → $11 Initiates Coverage On → Hold
08/04/2023 — Raymond James Downgrades Strong Buy → Outperform
05/11/2023 116.87% TD Cowen $14 → $18 Maintains Outperform
05/11/2023 89.76% Alliance Global Partners $13.15 → $15.75 Maintains Buy
03/21/2023 20.48% Jefferies $5.5 → $10 Downgrades Buy → Equal-Weight
11/04/2022 — Raymond James Upgrades Outperform → Strong Buy
03/07/2022 68.67% Cowen & Co. $28 → $14 Maintains Outperform
02/22/2022 177.11% Raymond James $28 → $23 Downgrades Strong Buy → Outperform
09/15/2020 — Jefferies Initiates Coverage On → Buy
09/10/2020 165.06% Lake Street → $22 Initiates Coverage On → Buy
04/01/2020 80.72% Cowen & Co. → $15 Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目标价格变动 评级变动 之前/当前的评级
11/28/2023 32.53% Stifel → 11 美元 启动覆盖范围开启 → 按住
08/04/2023 — 雷蒙德·詹姆 降级 强势买入 → 跑赢大盘
05/11/2023 116.87% TD Cowen 14 美元 → 18 美元 维护 跑赢大盘
05/11/2023 89.76% 联盟全球合作伙伴 13.15 美元 → 15.75 美元 维护 买
03/21/2023 20.48% 杰富瑞集团 5.5 美元 → 10 美元 降级 购买 → 等量权重
2022 年 4 月 11 日 — 雷蒙德·詹姆 升级 跑赢大盘 → 强势买入
03/07/2022 68.67% Cowen & Co. 28 美元 → 14 美元 维护 跑赢大盘
02/22/2022 177.11% 雷蒙德·詹姆 28 美元 → 23 美元 降级 强势买入 → 跑赢大盘
2020 年 9 月 15 日 — 杰富瑞集团 启动覆盖范围开启 → 购买
2020 年 10 月 9 日 165.06% 湖街 → 22 美元 启动覆盖范围开启 → 购买
2020 年 1 月 4 日 80.72% Cowen & Co. → 15 美元 启动覆盖范围开启 → 跑赢大盘

What is the target price for Profound Medical (PROF)?

Profound Medical（PROF）的目标价格是多少？

The latest price target for Profound Medical (NASDAQ: PROF) was reported by Stifel on November 28, 2023. The analyst firm set a price target for $11.00 expecting PROF to rise to within 12 months (a possible 32.53% upside). 5 analyst firms have reported ratings in the last year.

Stifel于2023年11月28日公布了Profound Medical（纳斯达克股票代码：PROF）的最新目标股价。该分析公司将目标股价定为11.00美元，预计PROF将在12个月内升至12个月内（可能上涨32.53％）。去年有5家分析公司公布了评级。

What is the most recent analyst rating for Profound Medical (PROF)?

Profound Medical（PROF）的最新分析师评级是多少？

The latest analyst rating for Profound Medical (NASDAQ: PROF) was provided by Stifel, and Profound Medical initiated their hold rating.

Stifel提供了Profuct Medical（纳斯达克股票代码：PROF）的最新分析师评级，而Profound Medical则启动了持有评级。

When is the next analyst rating going to be posted or updated for Profound Medical (PROF)?

Profound Medical（PROF）的下一次分析师评级将在何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Profound Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Profound Medical was filed on November 28, 2023 so you should expect the next rating to be made available sometime around November 28, 2024.

分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Profound Medical的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Profound Medical的最新评级是在2023年11月28日公布的，因此您应该预计下一个评级将在2024年11月28日左右公布。

Is the Analyst Rating Profound Medical (PROF) correct?

分析师对深远医疗（PROF）的评级是否正确？

While ratings are subjective and will change, the latest Profound Medical (PROF) rating was a initiated with a price target of $0.00 to $11.00. The current price Profound Medical (PROF) is trading at is $8.30, which is within the analyst's predicted range.

尽管评级是主观的，并且会发生变化，但最新的Profound Medical（PROF）评级已启动，目标股价为0.00美元至11.00美元。Profound Medical（PROF）目前的交易价格为8.30美元，在分析师的预测区间内。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发